Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 162.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 163.50p
  • 52 Week Low: 101.00p
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 92,277
  • Market Cap: £173.37m
  • RiskGrade: 470

Cello Health sells Pulsar business to Access Intelligence

By Michele Maatouk

Date: Wednesday 02 Oct 2019

LONDON (ShareCast) - (Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.
The AIM-listed company said on Wednesday that the disposal will allow it to focus its capital investment on the higher growth and higher margin healthcare business as well as supporting the development of the core Signal business.

The consideration will be satisfied through the issue of just over 8.6m ordinary shares of 5 pence each and a £1 cash payment. Following the acquisition, Cello will own around 11.3% of Access Intelligence.

Cello chief executive Mark Scott said: "We are delighted that Pulsar can now begin the next stage in its development as a business whilst enabling Cello to focus on its core healthcare activities. We look forward to the ongoing partnership with Access Intelligence, both as a shareholder and as an ongoing user of Pulsar."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 162.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 163.50p
52 Week Low 101.00p
Volume 92,277
Shares Issued 106.69m
Market Cap £173.37m
RiskGrade 470

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.93% below the market average85.93% below the market average85.93% below the market average85.93% below the market average85.93% below the market average
18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average
Price Trend
85.37% above the market average85.37% above the market average85.37% above the market average85.37% above the market average85.37% above the market average
45.00% above the sector average45.00% above the sector average45.00% above the sector average45.00% above the sector average45.00% above the sector average
Income
76.7% below the market average76.7% below the market average76.7% below the market average76.7% below the market average76.7% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
31.04% below the market average31.04% below the market average31.04% below the market average31.04% below the market average31.04% below the market average
35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 14-Jul-2020

Time Volume / Share Price
16:38 66,539 @ 162.08p
15:14 17,570 @ 162.00p
15:13 16,000 @ 162.00p
15:01 1,570 @ 162.00p
11:25 36,885 @ 162.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page